GILD stock news
This page provides real-time market news, earnings updates, and company announcements related to Gilead Sciences, Inc. (GILD).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-07 06:14 EST
Gilead Bets $2 Billion on Ouro, Banking on One Major Autoimmune Discovery
101 finance2026-03-23 22:46:00
Gilead's Ouro Bet: A High-Risk, High-Reward Autoimmune Play with Fast Track Momentum
101 finance2026-03-23 22:52:04
Gilead's Targeted Purchase of Ouro Medicines Drives Volume to 110th Place Amid Growth of Autoimmune Drug Pipeline
101 finance2026-03-23 23:00:55
Gilead acquires biotechnology company Ouro for up to $2.2 billion
格隆汇2026-03-24 02:03:13
Gilead plans to acquire Ouro Medicines for up to $2.175 billion
格隆汇2026-03-24 03:20:40
Gilead’s Bold Bet: Risky T Cell Engager May Deliver Lasting Immune Renewal or Deplete Expansion Funds
101 finance2026-03-24 04:52:01
Gilead Leaders Make Significant Sales Through Rule 10b5-1 Arrangements While Company Allocates $2.18 Billion for Ouro Purchase — Savvy Investors Raise Concerns About Short-Term Value Consistency
101 finance2026-03-24 11:16:15
Stock Market Today (LIVE): Gap Beats Rivals to AI Sales; United Swaps Coach for Costly Suites
101 finance2026-03-24 16:12:51
Gilead Expands Inflammation Pipeline Through Agreement With Ouro Medicines
101 finance2026-03-24 20:16:03
Arcus Executives Offload Shares Amid Surge in Hiring—A "Pump and Dump" Warning Sign for RCUS
101 finance2026-03-24 21:03:41
MaxCyte, Inc. (MXCT) Announces Fourth Quarter Loss, Falls Short of Revenue Projections
101 finance2026-03-24 22:40:18
ORKA Surges 8.4%: Biotech Titan Hits 52-Week Peak Amid Pipeline Optimism
101 finance2026-03-25 14:39:42
MESO Ignites 10% Surge: A Biotech Spark Ignited Without a Visible Fuse
101 finance2026-03-25 17:00:38
Mesoblast Soars: 9.5% Single-Day Jump Captures Attention of Biotech Observers
101 finance2026-03-25 19:09:55
Regencell Bioscience Sparks Momentum: 5.9% Jump Breaks Persistent Downward Pattern
101 finance2026-03-26 16:33:35
Insulet's Strong Fundamentals Clash With Bearish Tech Signals
101 finance2026-03-27 03:09:47
Is Gilead’s Long-Term Growth Prospects Enhanced by Its Latest Acquisitions?
101 finance2026-03-27 13:54:37
What Caused Gilead Sciences (GILD) to Fall More Sharply Than the Overall Market Today
101 finance2026-03-27 23:03:56
Gilead’s Bet in Cancer Treatment: A Valuation Shift Dependent on a Single FDA Ruling
101 finance2026-03-28 08:40:00
Gilead Sciences (GILD) Moves Up but Trails the Market: Key Points to Consider
101 finance2026-03-31 22:55:00
Barinthus Bio: CEO Departure and Dual CFO Roles Point to Leadership Gap Amidst Savvy Investors Exiting
101 finance2026-04-01 00:18:58
Gilead’s High-Stakes Gamgertamig Move: Phase 1b Results Will Determine Outcome of $1.675B Investment
101 finance2026-04-03 23:30:56
Galapagos Secures $500M in Cash for Greater Flexibility, Yet Market Doubts Remain Over Execution Challenges
101 finance2026-04-04 12:45:46
Pharmaceutical and biotechnology leaders accelerate mergers and acquisitions in the first quarter to strengthen their product portfolios
101 finance2026-04-06 20:15:50
Gilead plans to acquire Ouro Medicines for up to $2.175 billion
格隆汇2026-03-24 03:20:40
Gilead’s Bold Bet: Risky T Cell Engager May Deliver Lasting Immune Renewal or Deplete Expansion Funds
101 finance2026-03-24 04:52:01
Gilead Leaders Make Significant Sales Through Rule 10b5-1 Arrangements While Company Allocates $2.18 Billion for Ouro Purchase — Savvy Investors Raise Concerns About Short-Term Value Consistency
101 finance2026-03-24 11:16:15
Stock Market Today (LIVE): Gap Beats Rivals to AI Sales; United Swaps Coach for Costly Suites
101 finance2026-03-24 16:12:51
Gilead Expands Inflammation Pipeline Through Agreement With Ouro Medicines
101 finance2026-03-24 20:16:03
Arcus Executives Offload Shares Amid Surge in Hiring—A "Pump and Dump" Warning Sign for RCUS
101 finance2026-03-24 21:03:41
MaxCyte, Inc. (MXCT) Announces Fourth Quarter Loss, Falls Short of Revenue Projections
101 finance2026-03-24 22:40:18
ORKA Surges 8.4%: Biotech Titan Hits 52-Week Peak Amid Pipeline Optimism
101 finance2026-03-25 14:39:42
MESO Ignites 10% Surge: A Biotech Spark Ignited Without a Visible Fuse
101 finance2026-03-25 17:00:38
Mesoblast Soars: 9.5% Single-Day Jump Captures Attention of Biotech Observers
101 finance2026-03-25 19:09:55
Regencell Bioscience Sparks Momentum: 5.9% Jump Breaks Persistent Downward Pattern
101 finance2026-03-26 16:33:35
Insulet's Strong Fundamentals Clash With Bearish Tech Signals
101 finance2026-03-27 03:09:47
Is Gilead’s Long-Term Growth Prospects Enhanced by Its Latest Acquisitions?
101 finance2026-03-27 13:54:37
What Caused Gilead Sciences (GILD) to Fall More Sharply Than the Overall Market Today
101 finance2026-03-27 23:03:56
Gilead’s Bet in Cancer Treatment: A Valuation Shift Dependent on a Single FDA Ruling
101 finance2026-03-28 08:40:00
Gilead Sciences (GILD) Moves Up but Trails the Market: Key Points to Consider
101 finance2026-03-31 22:55:00
Barinthus Bio: CEO Departure and Dual CFO Roles Point to Leadership Gap Amidst Savvy Investors Exiting
101 finance2026-04-01 00:18:58
Gilead’s High-Stakes Gamgertamig Move: Phase 1b Results Will Determine Outcome of $1.675B Investment
101 finance2026-04-03 23:30:56
Galapagos Secures $500M in Cash for Greater Flexibility, Yet Market Doubts Remain Over Execution Challenges
101 finance2026-04-04 12:45:46
Pharmaceutical and biotechnology leaders accelerate mergers and acquisitions in the first quarter to strengthen their product portfolios
101 finance2026-04-06 20:15:50
GILD stock chart
GILD stock detailsGILD stock price change
On the last trading day, GILD stock closed at 139.71 USD, with a price change of -0.42% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more